For nearly three decades, scientists have been dedicated to unraveling the mysteries of creating human organs through lab-grown cells. A significant stride towards this ambitious goal is being made by Erin Bedford and her team at Aspect Biosystems, a Vancouver-based company pioneering a groundbreaking 3D printing process that utilizes human pancreas cells to address Type 1 diabetes.
Erin Bedford, now at the helm of bioprinting innovation, joined Aspect Biosystems in 2018 as one of its first employees. Armed with a freshly earned doctorate in nanotechnology from the University of Waterloo, Bedford sought a practical application for her expertise. She found the prospect of applying nanotechnology to replace and repair bodily functions through 3D-printed tissue immensely exciting, especially given its potential to address a significant and unmet medical need.
Continue reading… “Revolutionizing Diabetes Treatment: Vancouver-Based Aspect Biosystems Nears Breakthrough with 3D-Printed Pancreatic Tissues”